Calistoga Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
1/5/2011 9:10:25 AM
(BUSINESS WIRE)--Calistoga Pharmaceuticals, Inc., the leader in the development of delta-isoform-selective phosphatidylinositol 3-kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced that Carol Gallagher, President and Chief Executive Officer, will present at the 29th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2011 at 2:30 p.m. Pacific Time. The conference is taking place at the Westin St. Francis Hotel in San Francisco, California.
comments powered by